DK0944617T3 - Krystaller af benzimidazolderivater og deres fremstilling - Google Patents

Krystaller af benzimidazolderivater og deres fremstilling

Info

Publication number
DK0944617T3
DK0944617T3 DK97912445T DK97912445T DK0944617T3 DK 0944617 T3 DK0944617 T3 DK 0944617T3 DK 97912445 T DK97912445 T DK 97912445T DK 97912445 T DK97912445 T DK 97912445T DK 0944617 T3 DK0944617 T3 DK 0944617T3
Authority
DK
Denmark
Prior art keywords
substituted
optionally
crystals
preparation
benzimidazole derivatives
Prior art date
Application number
DK97912445T
Other languages
Danish (da)
English (en)
Inventor
Masayasu Kato
Toru Ishida
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17920069&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0944617(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DK0944617T3 publication Critical patent/DK0944617T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK97912445T 1996-11-14 1997-11-13 Krystaller af benzimidazolderivater og deres fremstilling DK0944617T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30336196 1996-11-14
PCT/JP1997/004136 WO1998021201A1 (en) 1996-11-14 1997-11-13 Crystals of benzimidazole derivatives and their production

Publications (1)

Publication Number Publication Date
DK0944617T3 true DK0944617T3 (da) 2003-09-01

Family

ID=17920069

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97912445T DK0944617T3 (da) 1996-11-14 1997-11-13 Krystaller af benzimidazolderivater og deres fremstilling

Country Status (19)

Country Link
US (1) US6002011A (xx)
EP (1) EP0944617B1 (xx)
KR (1) KR100519576B1 (xx)
CN (2) CN1171885C (xx)
AT (1) ATE240314T1 (xx)
AU (1) AU731776B2 (xx)
CA (1) CA2269053C (xx)
DE (1) DE69722027T2 (xx)
DK (1) DK0944617T3 (xx)
ES (1) ES2199356T3 (xx)
HK (1) HK1020194A1 (xx)
ID (1) ID21547A (xx)
IL (1) IL129724A (xx)
NZ (1) NZ335145A (xx)
PT (1) PT944617E (xx)
TR (1) TR199901055T2 (xx)
TW (1) TW385306B (xx)
WO (1) WO1998021201A1 (xx)
ZA (1) ZA9710255B (xx)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW385306B (en) * 1996-11-14 2000-03-21 Takeda Chemical Industries Ltd Method for producing crystals of benzimidazole derivatives
IL142703A (en) 1998-11-10 2006-04-10 Astrazeneca Ab Crystalline form of omeprazole
UA72748C2 (en) 1998-11-10 2005-04-15 Astrazeneca Ab A novel crystalline form of omeprazole
JP3926936B2 (ja) 1998-11-16 2007-06-06 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホキシド誘導体・アセトン錯体およびその製造法
JP2002536345A (ja) * 1999-02-04 2002-10-29 ジョルン ブラーディーク 間葉由来の組織変化を予防および／または治療するための製剤
TWI275587B (en) * 1999-06-17 2007-03-11 Takeda Chemical Industries Ltd A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
PL333847A1 (en) * 1999-06-18 2001-01-02 Inst Farmaceutyczny Crystalline forms of lansoprozole and method of obtaining lansoprazole in pharmacologically advanthageous crystalline form
AU5705700A (en) 1999-06-30 2001-01-22 Takeda Chemical Industries Ltd. Crystals of benzimidazole compounds
US7169799B2 (en) 2000-05-15 2007-01-30 Takeda Pharmaceutical Company Limited Process for producing crystal
CA2417311C (en) * 2000-08-04 2012-07-10 Takeda Chemical Industries, Ltd. Crystalline alkali metal salts of lansoprazole and their production and use
WO2002015908A1 (fr) 2000-08-18 2002-02-28 Takeda Chemical Industries, Ltd. Injections
EP1337525B8 (en) 2000-12-01 2011-10-05 Takeda Pharmaceutical Company Limited Process for the crystallization of (r)- or (s)-lansoprazole
DE10140492A1 (de) 2001-08-17 2003-08-14 Gruenenthal Gmbh Hydrate von gegebenenfalls substituierten 2-(2-Pyridinyl)methylthio-1H-benzimidazolen und Verfahren zu ihrer Herstellung
CA2463690C (en) 2001-10-17 2011-08-23 Takeda Chemical Industries, Ltd. Granules containing acid-unstable chemical in large amount
WO2003070665A2 (en) * 2002-02-19 2003-08-28 Teva Pharmaceutical Industries Ltd. Desolvating solvates of atorvastatin hemi-calcium
EP1476442A2 (en) * 2002-03-27 2004-11-17 Teva Pharmaceutical Industries Ltd. Lansoprazole polymorphs and processes for preparation thereof
KR100873419B1 (ko) * 2002-06-18 2008-12-11 페어차일드코리아반도체 주식회사 높은 항복 전압, 낮은 온 저항 및 작은 스위칭 손실을갖는 전력용 반도체 소자
TW200410955A (en) 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
EP1764364A1 (en) * 2002-08-21 2007-03-21 Teva Pharmaceutical Industries Ltd A method for the purification of lansoprazole
AU2003258335A1 (en) * 2002-08-21 2004-03-11 Teva Pharmaceutical Industries Ltd. A method for the purification of lansoprazole
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
ES2534713T3 (es) 2002-10-16 2015-04-27 Takeda Pharmaceutical Company Limited Preparaciones sólidas estables
EP1465890B1 (en) * 2002-11-18 2007-04-04 Teva Pharmaceutical Industries Ltd. Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
EP1743893A1 (en) 2002-11-18 2007-01-17 Teva Pharmaceutical Industries Ltd. Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
US7678816B2 (en) * 2003-02-05 2010-03-16 Teva Pharmaceutical Industries Ltd. Method of stabilizing lansoprazole
US7005732B2 (en) * 2003-10-21 2006-02-28 Honeywell International Inc. Methods and systems for providing MEMS devices with a top cap and upper sense plate
TW200526268A (en) * 2003-12-17 2005-08-16 Takeda Pharmaceutical Injectable composition
SE0400410D0 (sv) * 2004-02-20 2004-02-20 Astrazeneca Ab New compounds
JP5563735B2 (ja) 2004-06-16 2014-07-30 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド Ｐｐｉ多回剤形
EP1790647B1 (en) 2004-09-13 2013-05-08 Takeda Pharmaceutical Company Limited Method for producing oxidized compound
EP1681056A1 (en) 2005-01-14 2006-07-19 Krka Tovarna Zdravil, D.D., Novo Mesto Process for preparing lansoprazole
JP5124267B2 (ja) 2005-02-25 2013-01-23 武田薬品工業株式会社 顆粒の製造方法
US20090030044A1 (en) * 2005-06-07 2009-01-29 Takeda Pharmaceutical Company Limited Crystal of Salt of Benzimidazole Compound
US20090036406A1 (en) * 2005-06-13 2009-02-05 Takeda Pharmaceutical Company Limited Injection
CA2634969A1 (en) 2005-12-28 2007-07-05 Takeda Pharmaceutical Company Limited Controlled release solid preparation
KR100758600B1 (ko) * 2006-01-05 2007-09-13 주식회사 대웅제약 란소프라졸 결정형 ａ의 제조방법
US8129536B2 (en) * 2006-09-22 2012-03-06 Orchid Chemicals & Pharmaceuticals Limited Method for the purification of lansoprazole
EP2089379A4 (en) * 2006-12-07 2010-04-21 Hetero Drugs Ltd NEW CRYSTALLINE SHAPE OF LANSOPRAZOLE
ITMI20062481A1 (it) * 2006-12-22 2008-06-23 Recordati Chem Pharm Processo per la preparazione di lansoprazolo forma i microcristallino
EP2098250B1 (en) 2006-12-28 2016-09-28 Takeda Pharmaceutical Company Limited Orally disintegrating solid preparation
EP2292612A3 (en) * 2007-12-31 2011-05-04 Takeda Pharmaceutical Company Limited Crystalline solvated forms of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole
UY31695A (es) * 2008-03-10 2009-11-10 Takeda Pharmaceutical Cristal de compuestos de bencimidazol
WO2011004387A2 (en) 2009-06-18 2011-01-13 Matrix Laboratories Ltd Process for the preparation of dexlansoprazole polymorphic forms
WO2011098938A1 (en) * 2010-02-11 2011-08-18 Orchid Chemicals And Pharmaceuticals Limited Novel solvate of dexlansoprazole
KR101908748B1 (ko) 2010-12-03 2018-10-16 다케다 야쿠힌 고교 가부시키가이샤 구강내 붕괴정
BR112013014875A2 (pt) 2010-12-27 2016-10-18 Takeda Pharmaceutical tablete oralmente desintegrável
CN102180866B (zh) * 2011-05-23 2013-03-13 中山大学 兰索拉唑晶型及其制备方法和应用
CN103012369B (zh) * 2011-05-23 2014-04-23 中山大学 兰索拉唑n晶型及其制备方法和应用
AR089032A1 (es) 2011-11-30 2014-07-23 Takeda Pharmaceutical Comprimido recubierto seco
US9119769B2 (en) 2011-12-30 2015-09-01 The Curators Of The University Of Missouri Method for transforming pharmaceutical crystal forms
CN105392486A (zh) 2013-05-21 2016-03-09 武田药品工业株式会社 口腔崩解片
CN103539729A (zh) * 2013-10-14 2014-01-29 安徽国星生物化学有限公司 一种氯甲基吡啶衍生物的工业化生产方法
CN103539728A (zh) * 2013-10-14 2014-01-29 安徽国星生物化学有限公司 一种拉唑类药物中间体氯甲基吡啶衍生物的合成方法
CN104829594A (zh) * 2015-05-15 2015-08-12 苗怡文 一种治疗胃溃疡的药物兰索拉唑化合物
CN104817492B (zh) * 2015-05-22 2018-05-18 抚州三和医药化工有限公司 兰索拉唑中间体2-羟甲基-3-甲基-4-(2,2,2-三氟乙氧基）吡啶的分离纯化方法
KR102649498B1 (ko) 2023-12-06 2024-03-20 거산해운(주) 선사별 실시간 통합 예약 정보를 기반으로 한 화주의 해상 운송 예약 자동화 플랫폼 서비스 제공 방법, 장치 및 시스템

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
DK171989B1 (da) * 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
DE4018642C2 (de) * 1990-06-11 1993-11-25 Byk Gulden Lomberg Chem Fab Neue Salzform des 5-Difluormethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl]-1H-benzimitazol-Natriumsalzes
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
US5374730A (en) * 1993-11-04 1994-12-20 Torcan Chemical Ltd. Preparation of omeprazole and lansoprazole
GB2297550C2 (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
TW385306B (en) * 1996-11-14 2000-03-21 Takeda Chemical Industries Ltd Method for producing crystals of benzimidazole derivatives

Also Published As

Publication number Publication date
HK1020194A1 (en) 2000-03-31
TW385306B (en) 2000-03-21
NZ335145A (en) 2000-12-22
CN100355749C (zh) 2007-12-19
IL129724A0 (en) 2000-02-29
ATE240314T1 (de) 2003-05-15
KR20000053158A (ko) 2000-08-25
US6002011A (en) 1999-12-14
CN1616457A (zh) 2005-05-18
EP0944617A1 (en) 1999-09-29
CA2269053C (en) 2006-07-18
AU731776B2 (en) 2001-04-05
PT944617E (pt) 2003-08-29
CN1237167A (zh) 1999-12-01
TR199901055T2 (xx) 1999-07-21
WO1998021201A1 (en) 1998-05-22
CN1171885C (zh) 2004-10-20
EP0944617B1 (en) 2003-05-14
ID21547A (id) 1999-06-24
ES2199356T3 (es) 2004-02-16
AU4965297A (en) 1998-06-03
IL129724A (en) 2004-02-19
CA2269053A1 (en) 1998-05-22
DE69722027T2 (de) 2004-03-25
ZA9710255B (en) 1999-05-13
KR100519576B1 (ko) 2005-10-07
DE69722027D1 (de) 2003-06-18

Similar Documents

Publication Publication Date Title
DK0944617T3 (da) Krystaller af benzimidazolderivater og deres fremstilling
HUP9802859A2 (hu) Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként
DK0487071T3 (da) Kondenserede heterocykliske forbindelser, deres fremstilling og anvendelse
CA1272482C (en) QUINOLINECARBOXYLIC ACID DERIVATIVES
RO81943B (ro) Procedeu de preparare a unor derivati de piridoxina
EA199800759A1 (ru) 2-гетароилциклогексан-1,3-дионы
UA66756C2 (uk) Сполуки піперазину та піперидину, спосіб одержання сполук та спосіб лікування розладів центральної нервової системи
ES8704445A1 (es) Procedimiento de preparar derivados aminicos
DE3776044D1 (de) Pyridazinon-derivate.
NO892170L (no) Buten- eller propensyrederivater og fremgangsmaate for deres fremstilling.
DK0819108T3 (da) Fremgangsmåde til fremstilling af galanthaminderivater ved asymmetrisk reduktion
NO20073213L (no) Fremgangsmate for fremstilling av tiofenglykosidderivater
NO961537L (no) Salpetersyreestere fra derivater av 2-(2,6-dihalofenylamino)-fenylacetoksyeddiksyre, og deres fremstillingsprosedyrer
PT99280A (pt) Processo de preparacao de derivados do indolo e de composicoes farmaceuticas
BG60248B1 (bg) Метод за получаване на производни на феноксиетиламина
NO890158L (no) Fremgangsmaate for fremstilling av hydroksialkyleringsmiddel, de oppnaadde midler og deres anvendelse.
DK369289D0 (da) Anvendelse af imidazopyrazolderivater som analgetica og antiinflammatoriske midler
DK0413278T3 (da) Anvendelse af xanthinderivater mod mavesår
DE3772852D1 (de) Thiadiazolylacetamid-derivate, verfahren zu ihrer herstellung und ihre verwendung.
ATE19629T1 (de) N-substituierte derivate des tetrahydroisophthalimids.
NO934881L (no) Benzotiazolderivater, fremgangsmåte for deres fremstilling og farmasöytisk preparat derav
DK231787D0 (da) 3-amino-dihydropyridiner, fremgangsmaade til deres fremstilling og deres anvendelse i laegemidler
MY104164A (en) Heterocyclic compounds.
TW328088B (en) Imidazolidinone derivative and its acid additional salt, for treatment of senile dementia and the process for preparing them